Literature DB >> 8373932

Antipsychotic drugs block phencyclidine receptor-mediated neurotoxicity.

N B Farber1, M T Price, J Labruyere, J Nemnich, H St Peter, D F Wozniak, J W Olney.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8373932     DOI： 10.1016/0006-3223(93)90265-f

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  10 in total

Review 1.  Neuroprotective effect of atypical antipsychotics in cognitive and non-cognitive behavioral impairment in animal models.

Authors:  Jue He; Jiming Kong; Qing-Rong Tan; Xin-Min Li
Journal:  Cell Adh Migr       Date:  2009-01-13       Impact factor: 3.405

Review 2.  Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection.

Authors:  Jeffrey A Lieberman; Frank P Bymaster; Herbert Y Meltzer; Ariel Y Deutch; Gary E Duncan; Christine E Marx; June R Aprille; Donard S Dwyer; Xin-Min Li; Sahebarao P Mahadik; Ronald S Duman; Joseph H Porter; Josephine S Modica-Napolitano; Samuel S Newton; John G Csernansky
Journal:  Pharmacol Rev       Date:  2008-09       Impact factor: 25.468

3.  Expression of neurotrophins BDNF and NT-3, and their receptors in rat brain after administration of antipsychotic and psychotrophic agents.

Authors:  A M Lindén; J Väisänen; M Lakso; H Nawa; G Wong; E Castrén
Journal:  J Mol Neurosci       Date:  2000 Feb-Apr       Impact factor: 3.444

4.  Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man.

Authors:  Sargo Aalto; Jouni Ihalainen; Jussi Hirvonen; Jaana Kajander; Harry Scheinin; Heikki Tanila; Kjell Någren; Harry Vilkman; Lars L Gustafsson; Erkka Syvälahti; Jarmo Hietala
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

5.  Effects of NMDA-receptor antagonist treatment on c-fos expression in rat brain areas implicated in schizophrenia.

Authors:  Jussi Väisänen; Jouni Ihalainen; Heikki Tanila; Eero Castrén
Journal:  Cell Mol Neurobiol       Date:  2004-12       Impact factor: 5.046

6.  Clozapine treatment increases serum glutamate and aspartate compared to conventional neuroleptics.

Authors:  A E Evins; E T Amico; V Shih; D C Goff
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

7.  Assessment of NMDA receptor activation in vivo by Fos induction after challenge with the direct NMDA agonist (tetrazol-5-yl)glycine: effects of clozapine and haloperidol.

Authors:  K Inada; J S Farrington; S S Moy; B H Koller; G E Duncan
Journal:  J Neural Transm (Vienna)       Date:  2007-02-22       Impact factor: 3.850

8.  NMDA receptor function, memory, and brain aging.

Authors:  J W Newcomer; N B Farber; J W Olney
Journal:  Dialogues Clin Neurosci       Date:  2000-09       Impact factor: 5.986

9.  REL-1017 (Esmethadone), A Novel NMDAR Blocker for the Treatment of MDD is Not Neurotoxic in Sprague-Dawley Rats.

Authors:  Francesco Bifari; Marco Pappagallo; Michael Bleavins; Sergio Traversa; Franco Folli; Paolo L Manfredi
Journal:  Front Pharmacol       Date:  2022-04-25       Impact factor: 5.810

10.  An animal model of emotional blunting in schizophrenia.

Authors:  Charmaine Y Pietersen; Fokko J Bosker; Janine Doorduin; Minke E Jongsma; Folkert Postema; Joseph V Haas; Michael P Johnson; Tineke Koch; Tony Vladusich; Johan A den Boer
Journal:  PLoS One       Date:  2007-12-26       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.